List of Tables
Table 1. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Trends
Table 2. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Drivers & Opportunity
Table 3. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Challenges
Table 4. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Restraints
Table 5. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs
Table 10. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Roche Basic Information List
Table 32. Roche Description and Business Overview
Table 33. Roche Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business of Roche (2019-2024)
Table 35. Roche Recent Developments
Table 36. Regeneron Pharmaceuticals Basic Information List
Table 37. Regeneron Pharmaceuticals Description and Business Overview
Table 38. Regeneron Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business of Regeneron Pharmaceuticals (2019-2024)
Table 40. Regeneron Pharmaceuticals Recent Developments
Table 41. Bayer Basic Information List
Table 42. Bayer Description and Business Overview
Table 43. Bayer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business of Bayer (2019-2024)
Table 45. Bayer Recent Developments
Table 46. Santen Oy Basic Information List
Table 47. Santen Oy Description and Business Overview
Table 48. Santen Oy Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business of Santen Oy (2019-2024)
Table 50. Santen Oy Recent Developments
Table 51. Kanghong Pharmaceuticals Basic Information List
Table 52. Kanghong Pharmaceuticals Description and Business Overview
Table 53. Kanghong Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business of Kanghong Pharmaceuticals (2019-2024)
Table 55. Kanghong Pharmaceuticals Recent Developments
Table 56. Novartis Basic Information List
Table 57. Novartis Description and Business Overview
Table 58. Novartis Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business of Novartis (2019-2024)
Table 60. Novartis Recent Developments
Table 61. Eli Lilly and Company Basic Information List
Table 62. Eli Lilly and Company Description and Business Overview
Table 63. Eli Lilly and Company Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business of Eli Lilly and Company (2019-2024)
Table 65. Eli Lilly and Company Recent Developments
Table 66. TRACON Pharmaceuticals Basic Information List
Table 67. TRACON Pharmaceuticals Description and Business Overview
Table 68. TRACON Pharmaceuticals Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business of TRACON Pharmaceuticals (2019-2024)
Table 70. TRACON Pharmaceuticals Recent Developments
Table 71. Pfizer Basic Information List
Table 72. Pfizer Description and Business Overview
Table 73. Pfizer Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business of Pfizer (2019-2024)
Table 75. Pfizer Recent Developments
Table 76. GSK Basic Information List
Table 77. GSK Description and Business Overview
Table 78. GSK Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business of GSK (2019-2024)
Table 80. GSK Recent Developments
Table 81. BIOCAD Basic Information List
Table 82. BIOCAD Description and Business Overview
Table 83. BIOCAD Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Products, Services and Solutions
Table 84. Revenue (US$ Million) in Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Business of BIOCAD (2019-2024)
Table 85. BIOCAD Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Downstream Customers
Table 89. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Product Picture
Figure 2. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Report Years Considered
Figure 5. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Revenue in 2023
Figure 7. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Agonist Picture
Figure 9. Allosteric Modulator Picture
Figure 10. Kinase Inhibitor Picture
Figure 11. Monoclonal Antibody Picture
Figure 12. Others Picture
Figure 13. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Clinic
Figure 17. Product Picture of Others
Figure 18. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value (%), (2019-2030)
Figure 31. United States Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Application (%), 2023 VS 2030
Figure 37. China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Type (%), 2023 VS 2030
Figure 39. China Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. India Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Industrial Chain
Figure 53. Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
